Sign in

CIK 0001175151

  • Non-accelerated filer
  • Smaller reporting company

Cytosorbents Corp

Sign in to watch
Ticker
CTSO
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
980373793
Phone
+1 973-329-8885
Business address
305 COLLEGE ROAD EAST, PRINCETON, NJ, 08540
Former names
MedaSorb Technologies CORP, GILDER ENTERPRISES INC
Open-market buys, last 90 days
$120,435
in 4 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$120,435. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2011-09-06 Lamadrid David Chief Financial Officer Sale −12,500 $0.22 $3K 7,837,500
2011-09-06 Lamadrid David Chief Financial Officer Option exercise · Stock Option −12,500 7,837,500
2010-05-05 Lamadrid David Chief Financial Officer Grant or award · Stock Option +2,750,000 7,850,000
2010-01-04 Lamadrid David Chief Financial Officer Grant or award · Stock Option +400,000 5,100,000
2009-11-20 Lamadrid David Chief Financial Officer Sale −505,000 $0.17 $87K 3,734
2009-01-28 Lamadrid David Chief Financial Officer Grant or award · Stock Option +400,000 4,700,000
2008-06-25 Lamadrid David Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +2,750,000 2,750,000
2008-01-16 Lamadrid David Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +1,400,000 1,400,000
2008-01-16 Lamadrid David Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +1,400,000 1,400,000
2007-01-16 Lamadrid David Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +150,000 150,000
2006-10-25 Lamadrid David Chief Financial Officer Other acquisition +7,030 508,734

Page 1 of 1 · 11 trades